Reference of this article: Garcés Sánchez M. New vaccines´ development: vaccine against human papillomavirus. Criteria for its incorporation to the systematic inmunization schedule. Rev Pediatr Aten Primaria. 2007;9 Supl 3:S63-75.
Published in Internet: 31-12-2007 - Visits: 5109
In the last two decades, a better knowledge of immune system and interactions between
pathogens and human guest, involved in disease development, has proved to be crucial in the
research of new vaccines. A good example of this has been the human papillomavirus (HPV)
infection. Thus, high oncogenic risk types of HPV are involved in the development of cervix cancer. In those cases, a primary prevention strategy for HPV infection using prophylactic vaccines,
plays an important role in prevention of future cervix cancer. The imminent marketing
of HPV vaccine in our country, and its consequent inclusion in the Spanish Immunization
Schedule, will depend on the results of the analysis of all impact factors in health burden. We
primary care paediatricians are the final prescribers of vaccines, so we should know which criteria
have been evaluated by Sanitary Authorities. This paper analyzes each one of these criteria
for HPV vaccine.
Key words: Human papillomavirus, Vaccine, Cervical cancer, Immunization programs, Public
Keywords● Cervical cancer ● Human papillomavirus ● Immunization programs ● Vaccines